1-3 of 3
Angelo Michele Carella
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up

Available to Purchase
Subject Area:
Hematology , Oncology
Alessia Bari, Raffaella Marcheselli, Luigi Marcheselli, Isabel Alvarez, Samantha Pozzi, Paola Ferri, Antonio Lazzaro, Alberto Fragasso, Santo Neri, Luca Baldini, Angelo Michele Carella, Francesco Angrilli, Roberto Guariglia, Gabriele Buda, Caterina Stelitano, Stefano Sacchi, on behalf of the Gruppo Italiano Studio Linfomi (GISL)
Journal: Acta Haematologica
Acta Haematol (2017) 137 (1): 7–14.
https://doi.org/10.1159/000449052
Published Online: 01 January 2017
View article titled, A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up
Open the PDF for A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up in another window
Journal Articles

Equivalent Outcome of Autologous Stem Cell Transplantation and Reduced Intensity Conditioning Stem Cell Transplantation in Acute Myeloid Leukemia Patients with t(8;21) Translocation?

Available to Purchase
Subject Area:
Hematology , Oncology
Angelo Michele Carella
Journal: Acta Haematologica
Acta Haematol (2015) 133 (3): 264–265.
https://doi.org/10.1159/000365780
Published Online: 20 November 2014
View article titled, Equivalent Outcome of Autologous Stem Cell Transplantation and Reduced Intensity Conditioning Stem Cell Transplantation in Acute Myeloid Leukemia Patients with t(8;21) Translocation?
Open the PDF for Equivalent Outcome of Autologous Stem Cell Transplantation and Reduced Intensity Conditioning Stem Cell Transplantation in Acute Myeloid Leukemia Patients with t(8;21) Translocation? in another window
Journal Articles

The Significance of Minimal Residual Disease in Stem Cell Grafts and the Role of Purging: Is It Better to Purge in vivo or in vitro?

Available to Purchase
Subject Area:
Hematology , Oncology
Lorella Melillo, Nicola Cascavilla, Enrica Lerma, Maria Teresa Corsetti, Angelo Michele Carella
Journal: Acta Haematologica
Acta Haematol (2005) 114 (4): 206–213.
https://doi.org/10.1159/000088411
Published Online: 02 November 2005
View article titled, The Significance of Minimal Residual Disease in Stem Cell Grafts and the Role of Purging: Is It Better to Purge in vivo or in vitro?
Open the PDF for The Significance of Minimal Residual Disease in Stem Cell Grafts and the Role of Purging: Is It Better to Purge in vivo or in vitro? in another window